43
Participants
Start Date
May 2, 2022
Primary Completion Date
May 2, 2023
Study Completion Date
May 2, 2023
Collection of datas
The collected data are : sex, age, date of first immunotherapy cycle, dose, date of first consultation, objective refraction in spheric equivalent, keratometry, visual acuity, microcyst-like epithelial changes (MECs), location and density, corneal toxicity grade and complementary exams (topography, in vivo confocal microscopy).
CHU Dijon, Dijon
CHU de Limoges - Hôpital Dupuytren, Limoges
HCL- Croix Rousse, Lyon
Clinique Monticelli-Vélodrome, Marseille
CHRU de Nancy, Nancy
CHU Nice, Nice
APHP - Kremlin-Bicêtre, Paris
CHU Saint-Etienne, Saint-Etienne
CHRU Strasbourg, Strasbourg
CHU Toulouse, Toulouse
Centre Hospitalier Universitaire de Saint Etienne
OTHER